BOBBIE RAE VANGORDER: Open Payments
NPI 1154630366 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 75 payments from 21 companies in 2025. Trend: 2023 $1,047 · 2024 $1,202 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $331 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $123 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| Madrigal Pharmaceuticals | 2 | $85 |
| Amgen Inc. | 5 | $77 |
| PFIZER INC. | 4 | $70 |
| Lilly USA, LLC | 3 | $65 |
| Novo Nordisk Inc | 3 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Corcept Therapeutics | 2 | $55 |
Products named: VRAYLAR, Kerendia, UBRELVY, REZDIFFRA, AIRSUPRA, OTEZLA, GEMTESA, Korlym.
Industry payments across NY — which companies pay providers there.
